OnSite FOB Rapid Test A specific and sensitive colorectal cancer screening test.

Slides:



Advertisements
Similar presentations
Point of Care Testing: Hemoccult ® Fecal Occult Blood
Advertisements

By Dr Nahla Madan NCD Committee April The working group on the guideline The working Group Reviewing Group Dr. Ibtihal Al Reefy Dr. Badryia Yaser.
CT COLONOGRAPHY. CRC TRENDS  Incidence decreased by 7%  Mortality decreased by 20%  Five year survival rates increased by 12%
Colon and Rectal Cancer Update
1 Colorectal Cancer and Screening Cancer Screening Programs September 2013.
Use of Fecal Immunochemical Tests
Nursing and Lab partnering to perform
Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Colon Cancer Are You at Risk? Colorectal Cancer: What Is It?
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
What Everyone Should Know About Colon Cancer Prevention Maria T. Abreu, MD Chief, Division of Gastroenterology Professor of Medicine.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Y o u r C o u n t y C r u s a d e A g a in s t C a n c e r.
OnSite Syphilis Ab Rapid Test (Strip)
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.

Screening and Early Diagnosis of Colorectal Cancer
OnSite Gonorrhea Rapid Test (Strip)
OnSite Rota/Adeno Ag Rapid Test
Medical Parasitology Lab.
Colon-Rectal Cancer Keith Bradley, MD National Alliance of Research Associates Programs NARAP.
OnSite Chlamydia Ag Rapid Test
For Medical Clinical Staff WellOne Primary Medical and Dental Care Click here to move on.
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
COST CONCIOUSNESS PROJECT FECAL OCCULT BLOOD TEST (FOBT) – APPROPRIATE OR NOT APPROPRIATE? by Kelvin Nguyen 05/10/2013.
OnSite Rapid Test Procedure Training
Integrated Cancer Screening Colorectal Cancer Screening.
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Tryggvi Björn Stefánsson Dept of Surgery Landspitali University Hospital.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
OnSite HAV IgM Rapid Test Upgraded to Revision H for Better Sensitivity CTK-MK-PPT-R0090 Rev 1.0.
OnSite Toxo IgG/IgM Rapid Test Providing the Full Spectrum of Infection with Toxoplasma.
OnSite Rapid Test Procedure Training
J.W.S Setoh, J.Y.H Lee, G.Y Chen,L.Y.Q Kwek, E.T.H Tan KK Women’s and Children’s Hospital (SingHealth) Process Improvement With Use of Hemosure Immunochemical.
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
OnSite Leishmania Ab Rapid Test (Strip) Leishmania IgG / IgM Rapid Test A Leading Product On Market by Using CTK Licensed Patented Antigen.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
A CMH Community DocTalk with Robert Wayne, MD, FACS.
D. M. Kruss MD Kill the Cancer Do Screening now! Daniel M. Kruss, M.D. Kill the Cancer Do Screening now! Daniel M. Kruss, M.D.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
OnSite FOB Rapid Test. Hemoglobin Variants Hemoglobin variantsHemoglobin variants are a part of the normal embryonicembryonic and fetal development, but.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Better Health. No Hassles. Colorectal Cancer Facts – The 2 nd leading cause cancer-related deaths in the Nation – Highly preventable – Caused 49,920 deaths.
Models to Inform Recommendations About Preventive Services Perspective of the United States Preventive Services Task Force.
Colorectal Cancer Proposal of a Screening Program for Developing Countries with Emphasis on Costs.
CRC 45: The steps to eliminating Colorectal Cancer Diana Rusz December 12, 2012.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Presented by: Liz M. Baker, CHES NC Comprehensive Cancer Program 1.
Date of download: 7/1/2016 From: A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia Ann Intern Med. 2007;146(4): doi: /
A Pharmacy Based Bowel Cancer Screening Program. Did You Know? Bowel cancer kills more Australians each year than breast or prostate cancer (AIHW 2012.
Immunochemical Fecal Occult Blood Testing
Colon Cancer The Bottom Line
Colorectal Cancer Screening Guidelines
What you need to know about the Fecal Occult Blood Test
Cancer Screening.
Colorectal Cancer: Risk Prevention and Diagnosis
Different Tests to Detect Colonic Polyps
27th Annual Winter CME Conference
Colorectal Cancer Screening
Cancer screening PROF .MAZIN AL-HAWAZ.
Colorectal Cancer.
VIRTUAL COLONOSCOPY DR DEEPIKA SOLANKI.
FECAL OCCULT BLOOD TESTING USING SERACULT SLIDES
J.W.S Setoh, J.Y.H Lee, G.Y Chen,L.Y.Q Kwek, E.T.H Tan
Presentation transcript:

OnSite FOB Rapid Test A specific and sensitive colorectal cancer screening test

The third most common cancer worldwide o About 1.4 million new case (10% of all cancer) in 2012 o About 96,830 new case and 50,310 deaths in U.S. in 2014 More than 95% of CRC develop from untreated polyps Curable if found early Preventable by removing precancerous polyps - Colon and rectum cancers world map-Death- WHO 2004 Colorectal Cancer (CRC)

Colorectal Cancer Screening Methods Advantages of using the FOBT: Relatively simple; No cleansing of the colon is necessary Samples can be collected at home Low cost compared to other CRC screening tests Non invasive, do not cause bleeding or tearing of the colon’s lining Suitable for large population-based screening Screening MethodsTest IntervalShortage Fecal occult blood test (FOBT):Every 1-2 yr Fecal DNA testUncommonSpecific equipment Flexible sigmoidoscopyEvery 5 ysExpensive; Specialist Double contrast barium enema (DCBE)Every 5 ysSpecialist CT, MRIEvery 5 ysExpensive; Specialist ColonoscopyEvery 10 ysExpensive; Specialist

The Colorectal Prevention Policy in USA Screening for CRC (from at age 50 ys till 75 ys) by using: High-sensitivity, non invasive, fecal occult blood testing (FOBT) Invasive sigmoidoscopy or colonoscopy -recommend from US Preventive Services Task Force

Used to detect gastrointestinal disorders, such as: Cancer Polyps Colitis Diverticulitis FOBT Indications FOBT performed every 1-2 years in people over 50 can reduce the number of deaths due to CRC by 15-33%.

Two Major Types of FOBT Fecal Guaiac TestFecal immunochemical test (iFOBT) PrincipleChemical testImmunochemical test DetectionPseudo peroxidase activity of haem/Hb Globin antigen in hHb HistoryAn old methodOn the market in 90’s InterpretationColor change, hard to interpretClear, accurate reading SpecificityPoor, detect non hHbHighly specific for hHb Sensitivity>90,000 ng/mLAdjustable, as low as 25 ng/mL Accuracy<86%>= 95% Dietary & drug affected YesNo specimens3 required1 is sufficient; 2 recommended

OnSite FOB Rapid Test - An Ideal iFOBT 25 tests each kit, contains 25 test individual devices 25 fecal extraction tubes 25 specimen ID labels 1 IFU Key features Simple procedure, clear result, no equipment needed, minimal training Perform assay anywhere 24 month shelf life Room temperature storage

Collect specimen Shake vigorously 2 drops of sample 5-10 minutes Perform Assay - Simple, Rapid Procedure Protective cap

Only C line is developedBoth C and T line are developed Perform Assay - Clear, Easy-To-Read Result NegativePositive

OnSite FOB Rapid Test in comparison with other iFOBT on the market

The OnSite FOB Rapid Test has three levels of the analytical sensitivity to meet the needs from different market: 25 ng hHb/mL buffer 50 ng hHb/mL buffer 100 ng hHb/mL buffer OnSite FOB Rapid Test Has Three Sensitivity Levels

A wider detection range by the OnSite FOB Rapid Test eliminates the risk of false negative results from specimens with a high concentration of hemoglobin. Clinical Performance - Wider Detection Range 2 mg/mL buffer is the dose of hook effect by the most other iFOBTs hHb LevelOnSite IFOBT result 5 mg/mL hHbWeak positive 4 mg/mL hHbClear positive 3 mg/mL hHbClear positive 2 mg/mL hHbClear positive

OnSite FOB Rapid Test Leading iFOBTPositiveNegativeTotal Positive47148 Negative Total A total of 175 specimens were collected for the performance study. The OnSite FOB Rapid Test was compared side by side with a leading brand iFOBT marketed in U.S. and other regions. The results show that both tests have high degree of agreement. Relative Sensitivity: 97.9%, Relative Specificity: 99.2%, Overall Agreement: 98.9% Clinical Performance - High Accuracy

Hemoglobin Hb Concentration without Cross Reaction OnSite FOB Rapid TestOther iFOBT Bovine Hemoglobin2 mg/mL1 mg/mL Chicken Hemoglobin2 mg/mL1 mg/mL Fish Hemoglobin2 mg/mL1 mg/mL Goat Hemoglobin2 mg/mL1 mg/mL Horse Hemoglobin2 mg/mL1 mg/mL Pork Hemoglobin2 mg/mL1 mg/mL Sheep Hemoglobin2 mg/mL1 mg/mL Rabbit Hemoglobin2 mg/mL1 mg/mL Turkey Hemoglobin2 mg/mL1 mg/mL Hemoglobin from different species was added to negative specimens and weak positive specimens. The OnSite FOB Rapid Test displayed very low risk of cross reactivity compared to other iFOBT. So it has less possibility to cross react with sources of hemoglobin consumed by the patient as meat. Clinical Performance - Specific to hHb

Substance Concentration OnSite FOB Rapid Test NegativePositive ControlN/ANegativePositive Ascorbic Acid20 mg/dLNegativePositive Bilirubin100 mg/dLNegativePositive Caffeine40 mg/dLNegativePositive Glucose2,000 mg/dLNegativePositive Iron (Fe 3+/ Fe 2+) )5 mg/mLNegativePositive Horseradish Peroxidase20 mg/mLNegativePositive The OnSite FOB Rapid Test gives correct results with no interference from common medicine and dietary substances. Clinical Performance - No Known Interference

Clinical Validation Test Result Not Affected by Cooked/Uncooked Food Beef Chicken Fish Lamb Pork Turkey In addition, toilet bowl cleansers do not interfere with the results of the OnSite FOB Rapid Test. Broccoli Cabbage Cantaloupe Cauliflower Horseradish Parsnip Red radish Turnip In clinical practice, it has been demonstrated that the test result won’t by affected by a wide range of cooked or uncooked food, and no restricting diet or medication is needed for three days before testing.

We provide the external controls to ensure the proper performance of the assay, particularly when: A new operator uses the test kit, prior to performing test A new lot of test kits is used A new shipment of test kits is used The storage temperature of the kit falls outside of 2-30  C The temperature of the test area falls outside of  C To verify a higher than expected frequency of positive/negative results To investigate the cause of repeated invalid results Positivia FOB External Control Assure Product Performance

OnSite FOB Rapid Test - the Right Choice for You Non-invasive screening test o Simple procedure, fast result, low cost, and minimal training o Perform test anywhere Three levels of the sensitivity meet different needs o 25 ng hHb/mL buffer o 50 ng hHb/mL buffer o 100 ng hHb/mL buffer Wider detection range and specific to hHb 98.9% agreement with the leading iFOBT Positivia external FOB assay control is available

Contact Info.: Mesa Rim Rd. San Diego, CA USA Address: Telephone: 1 (858) Fax: 1 (858) Technical Support

QUALITY. INNOVATION. SIMPLICITY